IL1B and COVID-19: We found that serum concentrations of IL-1β (p = 0.0086) and IL-18 (p = 0.0025) were significantly higher in patients with severe COVID-19 as compared with those suffering from mild-to-moderate COVID-19 (Fig. 2A, B).